‎Dr. Jude Abourdan جود أبوردن‎ on Instagram: "The medication I started was Ocrevus-zunovo It is a subcutaneous (under-the-skin) formulation of ocrelizumab, a humanized monoclonal antibody used to treat multiple sclerosis (MS) - Targets CD20-positive B lymphocytes - Leads to B-cell depletion → reduces inflammation, demyelination, and disease progression in MS. . Within days–weeks, circulating B cells drop significantly, that increases infection risk, reduced immunoglobulin levels with long-term u